Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study

BACKGROUND: The use of COVID-19 convalescent plasma (CCP) for the treatment of SARS-CoV-2 infection in pregnancy is intriguing in view of its safety profile in pregnancy and historical precedence of the use of plasma for other viral illnesses. This study aimed to evaluate the use of CCP in pregnant...

Descripción completa

Detalles Bibliográficos
Autores principales: Adan, Heba, Harb, Deemah, Hazari, Komal, Abdelkareem, Widad, Khan, Fareeda Nikhat, Zouaoui, Maryam, Raouf, May, Elsawy, Doaa, Azar, Aida Joseph, Khamis, Amar Hassan, Ammar, Abeer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509581/
https://www.ncbi.nlm.nih.gov/pubmed/36155102
http://dx.doi.org/10.1186/s12884-022-05043-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509581/
https://www.ncbi.nlm.nih.gov/pubmed/36155102
http://dx.doi.org/10.1186/s12884-022-05043-w

Ejemplares similares